How can we do pharmacokinetic studies in the tropics?

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 95, Issue 4, 2001, Pages 347-351

  Simpson, Julie A ^a,e   Aarons, Leon ^b   White, Nicholas J ^c,d  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c MAHIDOL UNIVERSITY   (Thailand)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Antimalarial agents; Drugs; Nonlinear mixed effects modelling; Population pharmacokinetics; Tropics

Indexed keywords

ANTIMALARIAL AGENT; MEFLOQUINE;

CHEMICAL MODEL; HUMAN; MALARIA; REVIEW; TROPICAL MEDICINE;

ANTIMALARIALS; HUMANS; MALARIA; MEFLOQUINE; MODELS, CHEMICAL; TROPICAL MEDICINE;

EID: 0035408046     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(01)90178-6     Document Type: Review

References (29)

1. Aarons, L. (1992). Population pharmacokinetics. International Journal of Clinical Pharmacology, Therapy and Toxicology, 30, 520-522.
2. Aarons, L. (1993). Sparse data analysis. European Journal of Drug Metabolism and Pharmacokinetics, 18, 97-100.
3. Aarons, L. (1999). Software for population pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics, 36, 255-264.
4. Aarons, L., Balant, L. P., Mentre, F., Morselli, P., Rowland, M., Steimer, J. L. & Vozeh, S. (1996). Practical experience and issues in designing and performing population pharmacokinetic and pharmacodynamic studies. European Journal of Clinical Pharmacology, 49, 251-254.
5. Beal, S. L. & Sheiner, L. B. (1980). The NONMEM system. American Statistician, 34, 118-119.
6. Bergqvist, Y. & Domeij-Nyberg, B. (1983). Distribution of chloroquine and its metabolite desethyl-chloroquine in human blood cells and its implication for the quantitative determination of these compounds in serum. Journal of Chromatography, 272, 137-148.
7. Best, N. G., Tan, K. K. C., Gilks, W. R. & Spiegelhalter, D. J. (1995). Estimation of population pharmacokinetics using the Gibbs sampler. Journal of Pharmacokinetics and Biopharma-ceutics, 23, 407-435.
8. D'Argenio, D. Z. (1981). Optimal sampling times for pharmacokinetic experiments. Journal of Pharmacokinetics and Biopharmaceutics, 9, 739-756.
9. Davidian, M. & Giltinan, D. M. (1995). Nonlinear Models for Repeated Measurement Data. London: Chapman & Hall.
10. Ezzet, F., Mull, R. & Karbwang, J. (1998). The population pharmacokinetics of CGP 56697 and its effects on the therapeutic response in malaria patients. British Journal of Clinical Pharmacology, 46, 553-561.
11. Ezzet, F., van Vugt, M., Nosten, F., Looareesuwan, S. & White, N. J. (2000). Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria. Antimicrobial Agents and Chemotherapy, 44, 697-704.
12. Gibaldi, M. & Perrier, D. (1982). Pharmacokinetics. New York: Marcel Dekker.
13. Hassan Alin, M., Ashton, M., Kihamia, C. M., Mtey, G. J. & Bjorkman, A. (1996). Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 61-65.
14. Hussein, Z., Eaves, C. J., Hutchinson, D. B. & Canfield, C. J. (1996). Population pharmacokinetics of proguanil in patients with acute P. falciparum malaria after combined therapy with atovaquone. British Journal of Clinical Pharmacology, 42, 589-597.
15. Hussein, Z., Eaves, J., Hutchinson, D. B. & Canfield, C. J. (1997). Population pharmacokinetics of atovaquone in patients with acute malaria caused by Plasmodium falciparum. Clinical Pharmacology and Therapeutics, 61, 518-530.
16. Lindstrom, M. J. & Bates, D. M. (1990). Nonlinear mixed effects models for repeated measures data. Biometrics, 46, 673-687.
17. Mallet, A. (1986). A maximum likelihood estimation method for random coefficient regression models. Biometrika, 73, 645-656.
18. Mentré, F., Mallet, A. & Baccar, D. (1997). Optimal design in random-effects regression models. Biometrika, 84, 429-442.
19. Minto, C. & Schnider, T. (1998). Expanding clinical applications of population pharmacodynamic modelling. British Journal of Clinical Pharmacology, 46, 321-333.
20. Sheiner, L. B. & Benet, L. Z. (1985). Premarketing observational studies of population pharmacokinetics of new drugs. Clinical Pharmacology and Therapeutics, 38, 481-487.
21. Sidhu, J. S., Ashton, M., Huong, N. V., Hai, T. N., Karlsson, M. O., Sy, N. D., Jonsson, E. N. & Gong, L. D. (1998). Artemisinin population pharmacokinetics in children and adults with uncomplicated falciparum malaria. British Journal of Clinical Pharmacology, 45, 347-354.
22. Simpson, J. A., Price, R., ter Kuile, F., Teja-Isavadharm, P., Nosten, F., Chongsuphajaisiddhi, T., Looareesuwan, S., Aarons, L. & White, N. J. (1999). Population pharmacokinetics of mefloquine in patients with acute falciparum malaria. Clinical Pharmacology and Therapeutics, 66, 472-484.
23. Spiegelhalter, D. J., Thomas, A. & Gilks, W. R. (1997). BUGS Manual 0.60. Cambridge: MRC Biostatistics Unit.
24. Steimer, J. L., Mallet, A., Golmard, J. L. & Boisvieux, J. F. (1984). Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model. Drug Metabolism Reviews, 15, 265-292.
25. Sun, H., Fadiran, E. O., Jones, C. D., Lesko, L., Huang, S. M., Higgins, K., Hu, C., Machado, S., Maldonado, S., Williams, R., Hossain, M. & Ette, E. I. (1999). Population pharmacokinetics. A regulatory perspective. Clinical Pharmacokinetics, 37, 41-58.
26. Trouiller, P. & Olliaro, P. (1999). Drug development output from 1975 to 1996: what proportion for tropical diseases? International Journal of Infectious Diseases, 3, 61-63.
27. Vozeh, S., Steimer, J. L., Rowland, M., Morselli, P., Mentré, F., Balant, L. P. & Aarons, L. (1996). The use of population pharmacokinetics in drug development. Clinical Pharmacokinetics, 30, 81-93.
28. Whiting, B., Kelman, A. W. & Grevel, J. (1986). Population pharmacokinetics: theory and clinical application. Clinical Pharmacokinetics, 11, 387-401.
29. Winstanley, P. A. & Watkins, W. M. (1992). Pharmacology and parasitology: integrating experimental methods and approaches to falciparum malaria. British Journal of Clinical Pharmacology, 33, 575-581.